Innovent Biologics
- Total Funding$560 M
OverviewSuggest Edit
Innovent Biologics,Inc. is a leading biopharmaceutical company in China focused on the discovery, development and manufacturing of complex, high-end biologics for both the Asian and global markets that meet EMA and FDA/cGMP standards. Innovent has an expanding biologics pipeline focused on oncology, inflammatory diseases and ophthalmology. Innovent's strategy is to advance its internal pipeline of proprietary biologic drugs and establish in/out-licensing agreements with global pharmaceutical/biotech companies. Because of its location and emphasis on quality, Innovent is able to leverage China's cost-efficient environment without compromising its world-class quality standards.
| Type | Private | |
| Founded | 2011 | |
| HQ | Fangshan Qu, CN | Map |
| Website | cn.innoventbio.com |
Recent NewsAll News
- Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
- Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors
- IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting
- UNION therapeutics and Innovent Biologics enter into strategic collaboration and license agreement for orismilast, a next-generation PDE4 inhibitor for inflammatory dermatology conditions
Latest Updates
| Employees (est.) (May 2022) | 858 | (+4%) |
| Cybersecurity rating | C | More |
Innovent Biologics Office Locations
Innovent Biologics has an office in Fangshan Qu
Fangshan Qu, CN (HQ)
Dong Ping Jie
Innovent Biologics Financials and Metrics
Summary Metrics
Founding Date | 2011 |
Innovent Biologics total Funding | $560 m |
Innovent Biologics latest funding size | $150 m |
Time since last funding | 4 years ago |
Innovent Biologics investors | Temasek Holdings, Legend Capital, Lilly Ventures, Ally Bridge Group, Rock Springs Capital, Hillhouse Capital Group, Frontline BioVentures, F-Prime Capital Partners, Cormorant Asset Management, Eight Roads Ventures, China Life Investment Holding, Taikang Life Insurance, State Development & Investment Corporation (SDIC), Temasek, Lilly Asia Ventures, Capital Group Private Markets, Hillhouse, Lilly Asia Venture, Taikang Insurance, F-Prime Capital |
Innovent Biologics's latest funding round in April 2018 was reported to be $150 m. In total, Innovent Biologics has raised $560 m
Innovent Biologics Cybersecurity Score
Innovent Biologics Environment, Social & Governance (ESG) Ratings
Innovent Biologics Online and Social Media Presence
Innovent Biologics's Trends
Innovent Biologics News and Updates
January 10, 2022
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
Agreement combines IASO Bio and Innovent’s CAR construct, validated in clinical trials, with Sana’s in vivo and ex vivo engineered cell therapy programs Agreement combines IASO Bio and Innovent’s CAR construct, validated in clinical trials, with Sana’s in vivo and ex vivo engineered cell therapy pro…
January 09, 2022
Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors
SHANGHAI, China and WARREN, N.J., Jan. 9, 2022 /PRNewswire/ -- Today, Laekna Therapeutics announced that the investigational new drug (IND) application of a combination therapy for the phase 1/2 clinical trial in patients with solid tumors who have been refractory to treatment with...
December 13, 2021
IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting
SAN JOSE and SAN FRANCISCO and NANJING, China, Dec. 12, 2021 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing innovative medicines and Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a...
September 28, 2021
UNION therapeutics and Innovent Biologics enter into strategic collaboration and license agreement for orismilast, a next-generation PDE4 inhibitor for inflammatory dermatology conditions
HELLERUP, Denmark, SAN FRANCISCO and SUZHOU, China, Sept. 28, 2021 /PRNewswire/ -- UNION therapeutics A/S ('UNION'), a privately-held, multi-asset, clinical stage, pharmaceutical company focused on immunology and infectious diseases, and Innovent Biologics (HK) Limited, a subsidiary of...
August 26, 2021
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs
REDWOOD CITY, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune system…
June 01, 2021
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China
SAN FRANCISCO and SUZHOU, China, May 31, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major...
Innovent Biologics Frequently Asked Questions
When was Innovent Biologics founded?
Innovent Biologics was founded in 2011.
How many employees does Innovent Biologics have?
Innovent Biologics has 858 employees.
Who are Innovent Biologics competitors?
Competitors of Innovent Biologics include Roivant Sciences, Legend Biotech and ILC Therapeutics.
Where is Innovent Biologics headquarters?
Innovent Biologics headquarters is located at Dong Ping Jie, Fangshan Qu.
Where are Innovent Biologics offices?
Innovent Biologics has an office in Fangshan Qu.
How many offices does Innovent Biologics have?
Innovent Biologics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies